Stocktoria
BriaCell Therapeutics Corp. BCTXL
Nasdaq · XNAS · stock · Pharmaceutical Preparations
BriaCell Therapeutics Corp. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -121.5% | -81.6% | -74.7% | -63.0% | -23.8% |
| Return on equity | -151.8% | 178.5% | 537.5% | -259.8% | -49.9% |
| Current ratio | 5.01 | 0.49 | 14.96 | 45.00 | 103.81 |
Source: SEC EDGAR filings · CIK 0001610820 · as of 2025-07-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.